By selecting a country, you will see contents with local focus. Contents that are not available in the local language, will be shown in English.

- Our Company
  
  We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.
  About Our Company
- Rare Diseases And Symptoms
  
  We at AOP Orphan focus on rare diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.
  About Rare Diseases And Symptoms
  - HematoOncology
  - Cardiology & Pulmonology
  - Neurology & Metabolic Disorders
- Individual Treatments
  
  Our strategic goal at AOP Orphan is to constantly deliver new treatment options for the patients with rare disease. Learn more about the current product portfolio and countries' availability here.
  About Individual Treatments
- Science & Innovation
  
  We at AOP Orphan aim to continue making a valuable contribution through our core competence in the medical research of rare diseases for the benefits of the patients. Learn more about our current studies, pipeline and publications here.
  About Science & Innovation
- Partnering
  
  We at AOP Orphan believe that getting connected and cooperating, growing the network and expanding the business can accelerate discovering, development and providing of therapies for patients with rare diseases. Learn more about the way we cooperate here.
  About Partnering
- Join Us
  
  Agile, ambitious and aligned team members, mutual appreciation and commitment - this is what makes AOP Orphan a successful company and great place to work. Learn more about the company, open positions and everyday life at AOP Orphan here.
  About Join Us
  - HR Contacts
  - Jobs

Product Overview

Portfolio AOP Orphan

A Product overview with focus on Rare Diseases.

Home
Individual Treatments

Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

Cardiology & Pulmonology

Empesin®

Empesin® is used for the treatment of catecholamine refractory hypotension following septic shock in patients older than 18 years. A catecholamine refractory hypotension is present if the mean arterial blood pressur cannot be stabilized to 65 – 75 mmHg despite adequate volume substitution and application of catecholamines.

Drug Facts

Active Ingredient

Agripressin

Cardiology & Pulmonology

Nexodal

Nexodal is for complete or partial reversal of CNS and especially respiratory depression, caused by natural or synthetic opioids.

Drug Facts

Active Ingredient

Naloxone Hydrochloride Dihydrate

Cardiology & Pulmonology

Raploc®

Tadalafil AOP is used to treat adults with pulmonary arterial hypertension (PAH) to improve exercise capacity

Drug Facts

Active Ingredient

Landiolol Hydrochloride

Cardiology & Pulmonology

Tadalafil AOP

Tadalafil AOP is used to treat adults with pulmonary arterial hypertension (PAH) to improve exercise capacity

Drug Facts

Active Ingredient

Tadalafil